• Experienced M&A Advisors
    • Deep Healthcare Industry Expertise
    • Personally Committed
  • Exceed Expectations
    • Strategic
    • Strategic
    • Transaction
    • Transaction
    • Healthcare
    • Healthcare
    • Expertise
    • Expertise
    • Excellence
    • Excellence
    • Experience
    • Experience
    Exceptional Execution
  • We Maximize Value
    • Trusted Advisors
      We seek to earn your confidence and trust. We hold ourselves to the highest standards of ethics and integrity. Our extensive experience allows us to advise you on the most sensitive, critical, complex and value determining strategic initiatives. Your clients, employees, shareholders and families all depend on you. You can depend on us with (and in) confidence.
    • Proven Track Record
      Our senior partners have closed 100+ transactions representing over $30B in total value in their careers. We are experts at achieving the optimal outcome for our clients. We maximize value, securing the highest price on the best possible terms, and in all cases strive to exceed expectations.
    • Extensive Relationship Network
      Our senior partners have 60+ years of combined Investment banking and strategic transaction experience. We have developed an exceptionally broad network of relationships over our careers, which we put to work on your behalf.
    • Healthcare Experts
      Our senior partners have 50+ years of dedicated healthcare experience. Healthcare businesses operate in a unique environment, with complex regulatory, reimbursement and intellectual property considerations. Our dedicated healthcare focus provides us with an unsurpassed depth of understanding and expertise that enables us to achieve the optimal results for our clients.
    • Conflict-Free Representation
      As a private partnership, we are free from the conflicts faced by firms that provide research, trading, represent large corporations or that seek to curry favor with private equity buyers (although we do like curry).
    • Senior Partner Attention
      A senior partner leads each and every one of our transactions from kick-off to closing. This senior level attention assures that our clients receive the highest level of advisory expertise available.
  • We Understandwe are

    Entrepreneurs, Founders, Owners

  • services
    services
    • Mergers and Acquisitions Advisory:
      • Sell-Side Advisory
      • Buy-Side Advisory
      • Exclusive sale
      • Private equity recapitalization
      • Corporate divestiture
      • Corporate partnering
      • Leveraged/Management
    • Financings
    • Valuations and Fairness Opinions
    • Pharmaceutical Products Partnering
  • focus
    focus
    • Healthcare Services
    • HIT
    • Physician Services
    • MedTech
    • Pharmaceutical Services
    • Life Sciences
  • clients
    clients
    • Founders
    • Owners
    • Public Companies
    • Entrepreneurs
    • Private companies
    • Investors

Edgemont Capital®

Edgemont Capital Partners®

Recently
Completed Transactions

Our Principals Have Closed Over 100 Transactions Representing More than $30 billion in Total Value

    Array
    (
        [0] => http://i2.wp.com/www.edgemontcapital.com/wp-content/uploads/2015/12/55-Top.png?fit=194%2C90
        [1] => 194
        [2] => 90
    )
    
  • TRANSACTION OVERVIEW
    acquired by
    December 2015
    • Premier Emergency Medical Specialists
    • Limited Exclusive Sale
    • Chandler, AZ
    • Dr. Evan Leibner, CEO
    • Edgemont Capital Partners acted as exclusive financial advisor to PEMS in its sale to Sheridan Healthcare, the Physician Services division of AmSurg Corp.
    • Confidential
    • PEMS provides emergency medicine staffing for two Dignity Health system facilities in the Phoenix metropolitan area

    Case Study: Premier Emergency Medical Specialists

    Edgemont served as the exclusive financial advisor to Premier Emergency Medical Specialists (“PEMS”) in its sale to Sheridan

    • PEMS had established a very solid presence within the Dignity Health system in the greater Phoenix market
    • PEMS’ leadership felt resource challenged in responding to Dignity’s requests to provide emergency medicine staffing at additional Dignity facilities
    • Significant HOCS mergers and acquisitions were occurring in Phoenix, reshaping hospital alignment and relationships
      • Emergency Medicine
      • Hospital Medicine
      • Anesthesia
    • PEMS had been approached and received an offer from a private equity-backed rollup, which offered significant equity and contingent value
    • PEMS retained Edgemont in February 2015 to explore and advise the company on a strategic sale process including the existing offer
    • Edgemont prepared an information packet, contacted strategic buyers and generated five written initial offers
    • PEMS met with three groups and proceeded into detailed due diligence, culminating in multiple final bids with valuations well in excess of initial offers
    • PEMS closed with Sheridan in December 2015 on a very favorable valuation and terms

    Edgemont Capital Partners Completes Sale of Premier Emergency Medical Specialists to Sheridan

    Healthcare investment banking firm serves as exclusive financial advisor to PEMS, one of the leading independent Emergency Medicine physician groups in Arizona

    NEW YORK and PHOENIX, December 7, 2015 — Edgemont Capital Partners, L.P., a leading independent investment banking firm providing M&A advisory services to healthcare companies, today announced that it has acted as exclusive financial advisor to Premier Emergency Medical Specialists, PLLC (“PEMS”) in its sale to Sheridan, the Physician Services division of AmSurg Corp. (NASDAQ:AMSG).  The transaction closed on December 4, 2015 and was led by Edgemont managing directors Jeff Swearingen and Luke Mitchell.

    Mr. Swearingen, co-founder of Edgemont, and head of the firm’s Physician Services Group, said, “We continue to see substantial interest in consolidation across multiple physician specialties, driven by the changing economics of the healthcare industry.  While 2015 has been a very active year for both buyers and sellers, the market dynamics suggest that this trend is likely to continue going into 2016 and beyond.”

    Mr. Mitchell, partner at Edgemont, and leader of the firm’s office-based Physician Services initiatives, added, “The acquisition of PEMS by Sheridan is the kind of high quality transaction that creates substantial benefits for both parties.  We were delighted to have the opportunity to work with these two outstanding management teams in order to make this transaction a reality.”

    PEMS was established in 2003 and provides emergency medicine staffing for two Dignity Health system facilities in the Phoenix metropolitan area: Chandler Regional Medical Center and Mercy Gilbert Medical Center.  PEMS’s more than 50 physicians and advanced practice clinicians care for over 120,000 patients annually, and PEMS is consistently ranked as one of the highest performing emergency medicine groups within the entire multi-state Dignity Health system.

    Dr. Evan Leibner, President and Chief Executive Officer of PEMS commented, “The close of this transaction, and the beginning of our partnership with Sheridan, is a tremendous outcome for our shareholders, all of our clinicians, our partners at Dignity, and the patients and communities we serve.  The combination of PEMS’ exceptional emergency medicine clinical care and Sheridan’s operational, IT, and financial systems and best practices, will ensure that together we are able to continue to be leaders in improving emergency medicine, not just in Arizona, but the entire region.”

    Dr. Leibner continued, “We are grateful to the Edgemont team for their expert advice and guidance throughout the sale process.  Their professionalism and dedication to this engagement, and the depth of their industry experience, resulted in a competitive process that brought us an outstanding partner.”

    The sale of PEMS represents Edgemont’s eighth closed transaction on behalf of hospital-based physician groups and management companies, and third in emergency medicine.  Edgemont previously represented Premier Physician Services, Inc. (of Dayton, Ohio) in its sale to TeamHealth Holdings Inc. (NYSE: TMH), Practice Support Resources, LLC in its sale to Intermedix Corporation, Milford Anesthesia Associates in its sale to Envision Healthcare Holdings, Inc. (NYSE: EVHC); South Oakland Anesthesia Associates in its sale to MEDNAX, Inc. (NYSE: MD); Wolverine Anesthesia Consultants in its sale to TeamHealth Holdings Inc.; New Jersey Anesthesia Associates in its sale to MEDNAX, Inc.; and Anesthesia Services Associates in its sale to PhyMed Management, LLC

    Associate Vitaliy Marchenko and Analyst Yaffet Menna completed the Edgemont transaction team.  Terry Roman, partner at Snell & Wilmer, and Brad Martorana, counsel, served as legal counsel to PEMS.

    About Edgemont Capital Partners, L.P.

    Edgemont Capital Partners, L.P. (www.edgemontcapital.com) is a specialty M&A advisory firm dedicated to providing the highest quality strategic advisory and capital raising services to healthcare companies.  The firm’s deep healthcare industry knowledge, extensive relationship network and substantial transaction expertise allows Edgemont to address healthcare companies’ strategic and financing needs with great success. Edgemont Capital Partners, L.P. provides sell-side and acquisition advisory, restructuring advisory, board advisory and private placement services.

    For more information on Edgemont Capital Partners, L.P.’s efforts in Physician Services contact Jeff Swearingen at +1 (212) 867-8938.

    Investment banking services are provided by Edgemont Capital Partners, L.P., a registered broker-dealer and member of FINRA and SIPC.

    Premier Emergency Medical Specialists

    “We are grateful to the Edgemont team for their expert advice and guidance throughout the sale process.  Their professionalism and dedication to this engagement, and the depth of their industry experience, resulted in a competitive process that brought us an outstanding partner.”

    Dr. Evan Leibner
    CEO
    Premier Emergency Medical Specialists

     

  • Array
    (
        [0] => http://i1.wp.com/www.edgemontcapital.com/wp-content/uploads/2015/11/54-Top.jpg?fit=250%2C189
        [1] => 250
        [2] => 189
    )
    
  • TRANSACTION OVERVIEW
    acquired by
    November 2015
    • Anesthesia Services Associates
    • Focused Exclusive Sale
    • Nashville, TN
    • Dr. Steve Dickerson, Senior Clinician
    • Edgemont Capital Partners acted as exclusive financial advisor to ASA in its sale to PhyMed
    • Confidential
    • ASA provides anesthesia department management and staffing for TriStar Hendersonville Medical Center, an HCA hospital and several ambulatory surgery centers

    Case Study: Anesthesia Services Associates 

    Edgemont served as the exclusive financial advisor to Anesthesia Services Associates (“ASA”) in its sale to PhyMed

    • ASA engaged Edgemont to explore a range of strategic and financial alternatives for its two divisions, Comprehensive Pain Specialists ("CPS") and ASA's hospital-based anesthesia division ("ASA OR")
      • CPS is a large and growing office-based interventional pain management group with over 50 office locations
    • Given CPS' legal structure, Edgemont recommended the sale of ASA OR through an asset sale structure and exploring a subsequent private equity recapitalization for CPS after completing the ASA OR disvestiture
    • PhyMed was the most logical strategic buyer for ASA OR given its presence in Nashville. Edgemont approached PhyMed with the opportunity and it made an initial offer
    • PhyMed's initial offer valuation was viewed as inadequate, and Edgemont approached another logical buyer to create a stalking horse bid
      • Edgemont's stalking horse strategy generated a superior offer from another acquirer
    • As a result of the competitive bidding dynamic, PhyMed significantly increased the valuation of its offer and closed the transaction on an accelerated time frame

    Edgemont Capital Partners Supports Anesthesia Services Associates in Completed Sale to PhyMed

    Healthcare investment banking firm serves as exclusive financial advisor to ASA

    NEW YORK and NASHVILLE, November 19, 2015 — Edgemont Capital Partners, LP (“Edgemont”), a leading independent investment banking firm providing M&A advisory services to healthcare companies, today announced that it acted as exclusive financial advisor to Anesthesia Services Associates, PLLC (“ASA”) in its sale to PhyMed Management, LLC. Terms of the transaction were not disclosed.

    ASA provides anesthesia department management and staffing for TriStar Hendersonville Medical Center, an HCA hospital and several ambulatory surgery centers.  The transaction closed on November 16, 2015.  Jeff Swearingen, managing director, co-founder of Edgemont, and head of the firm’s Physician Services Group, led the Edgemont engagement team, along with Luke Mitchell and Reid Petersen.  Brent Hill of Waller Lansden Dortch & Davis, LLP acted as legal counsel to ASA in the transaction.

    The sale of ASA is Edgemont’s seventh closed transaction on behalf of hospital-based physician groups and management companies and fifth in anesthesia.  Edgemont has now served as exclusive advisor to anesthesia practices and management companies that account for over 400,000 annual cases.  Edgemont previously represented Milford Anesthesia Associates in its sale to Envision Healthcare Holdings, Inc. (NYSE: EVHC); South Oakland Anesthesia Associates in its sale to MEDNAX, Inc. (NYSE: MD); Wolverine Anesthesia Consultants in its sale to TeamHealth Holdings Inc. (NYSE: TMH), and New Jersey Anesthesia Associates in its sale to MEDNAX, Inc. (NYSE: MD).  Edgemont also advised Premier Physician Services, Inc. in its sale to TeamHealth Holdings Inc. (NYSE: TMH), and Practice Support Resources, LLC in its sale to Intermedix Corporation.

    “Independent, high quality physician practices of scale are seeking the highest level of quality and experience in the financial advisors they hire,” said Mr. Swearingen.  “Edgemont is unsurpassed in its success in advising physician practices.”

    About Edgemont Capital Partners, L.P.

    Edgemont Capital Partners, LP (www.edgemontcapital.com) is a leading independent investment banking firm founded in 2001 providing the highest quality strategic advisory and capital raising services to healthcare companies.  The firm’s deep healthcare industry knowledge, broad relationship network and extensive transaction expertise allow Edgemont to address healthcare companies’ strategic and financing needs with great success. The firm’s principals have closed over 100 transactions, representing more than $30 billion in value.

    For more information on Edgemont’s efforts in Physician Services contact Jeff Swearingen at +1 (212) 867-8938.

    Investment banking services are provided by Edgemont Capital Partners, LP, a registered broker-dealer and member of FINRA and SIPC.

    Anesthesia Services Associates

    “Edgemont’s anesthesia industry relationships and transaction expertise helped ASA to maximize the value of our practice with the best strategic partner for our group.”

    Dr. Steven Dickerson
    Senior Clinician
    Anesthesia Services Associates 

  • Array
    (
        [0] => http://i0.wp.com/www.edgemontcapital.com/wp-content/uploads/2015/11/53-Top.png?fit=250%2C79
        [1] => 250
        [2] => 79
    )
    
  • TRANSACTION OVERVIEW
    recapitalized by
    October 2015
    • WorkWell Medical Group
    • Recapitalization
    • Salinas, CA
    • Dr. Sheilaja Mittal, CEO and Vikram Mittal
    • Edgemont Capital Partners acted as exclusive financial advisor to WorkWell in its recapitalization by Salt Creek Capital
    • Confidential
    • WorkWell is a leading independent urgent care and occupational medicine provider in California

    Case Study: WorkWell Medical Group

    Edgemont served as the exclusive financial advisor to WorkWell Medical Group ("WorkWell") in its recapitalization by Salt Creek Capital

    • Edgemont was retained by WorkWell in February 2015 to advise the founding wife-husband team of Dr. Sheilaja Mittal and Mr. Vikram Mittal on their strategic options
    • The owners were seeking a partner with meaningful experience growing a healthcare business, who could help capitalize on attractive market opportunities in central California
    • Edgemont reviewed Workwell’s financials and helped prepare the company for the potential partnership
      • Edgemont worked with the Mittals to identify and retain key transaction accounting and tax support
    • Edgemont recommended a broad auction process to include strategic acquirers and financial investors
      • Edgemont received significant interest from both groups of potential partners
    • WorkWell completed a transaction with Salt Creek Capital in October 2015
      • Edgemont ran a very competitive sale process with WorkWell receiving multiple, attractive final offers

    Edgemont Capital Partners Advises WorkWell Medical Group In Equity Investment By Salt Creek Capital

    Healthcare investment banking firm serves as exclusive financial advisor to WorkWell, the leading provider of occupational medicine and urgent care services in central California

    NEW YORK and SALINAS, C.A., November 10, 2015 — Edgemont Capital Partners, LP, a leading independent investment banking firm providing M&A advisory services to healthcare companies, today announced that it acted as exclusive financial advisor to WorkWell Medical Group, LLC (“WorkWell”) in its investment and recapitalization by Salt Creek Capital.  Terms of the deal were not disclosed.

    WorkWell Medical Group (www.workwellmedical.com), founded in 2003 by Dr. Sheilaja Mittal and Vikram Mittal, and headquartered in Salinas, California, offers patients and employers an in-house network of specialists, a multidisciplinary rehabilitation facility and a state-of-the-art mobile medical clinic, all providing a complete suite of healthcare services to improve healing time for employees, enabling them to return to work more quickly.  The company owns and manages five medical clinics providing occupational medicine, workers compensation care and case management, as well as urgent care services throughout the central coast of California.  The transaction closed on October 22, 2015.  Luke J. Mitchell, managing director, and leader of the firm’s efforts with office-based physician services groups, led the Edgemont engagement team, along with associate Vitaliy Marchenko.

    The recapitalization of WorkWell is Edgemont’s seventh closed transaction on behalf of physician groups, clinics, and practice management companies.

    “Through twelve years of dedication and tireless devotion to quality clinical care and patient satisfaction, WorkWell has earned its reputation throughout California and the Western U.S. as being the go-to provider of walk-in medical services for patients and employers in central California,” said Mr. Mitchell.  “Workwell was seeking a financial partner to provide the experience, capital, and management expertise to support the company’s tremendous growth, including its plans to expand to other parts of California.  Out of a comprehensive and highly competitive marketing process, Edgemont identified Salt Creek as an ideal partner for Workwell.”

    “After interviewing several firms we chose to work with Edgemont based on their long track record of working on behalf of medical practices and healthcare entrepreneurs, and their commitment to helping us achieve our personal and professional goals,” said Dr. and Mr. Mittal, founders of WorkWell.  “From the beginning of the engagement, Luke and the Edgemont team demonstrated a strong understanding of our business, and were able to effectively communicate our vision and strategy to the universe of potential partners.  The Edgemont team provided exceptional advice and brought us a range of highly attractive, and actionable, strategic options that resulted in a great outcome for us, WorkWell, our employees, and our customers.”

    About WorkWell

    Founded in 2003, WorkWell is the largest independent occupational medicine and urgent care provider in Central California.  The Company is a provider of choice for major employers and medical provider networks in California’s Central Coast.  More information can be found at www.workwellmedical.com.

    About Salt Creek Capital

    Salt Creek Capital is a San Francisco Bay Area-based private equity firm partnering with experienced operating executives to acquire profitable companies with up to $100 million in revenue. Salt Creek takes a long-term approach to investing in lower middle market businesses and seeks to create value by working closely with management teams to accelerate growth and to improve the operating efficiency of its portfolio companies. More information is available at www.saltcreekcap.com.

    About Edgemont Capital Partners, L.P.

    Edgemont Capital Partners, LP (www.edgemontcapital.com) is a leading independent investment banking firm founded in 2001 providing the highest quality strategic advisory and capital raising services to healthcare companies.  The firm’s deep healthcare industry knowledge, broad relationship network and extensive transaction expertise allows Edgemont to address healthcare companies’ strategic and financing needs with great success. The firm’s principals have closed over 100 transactions, representing more than $30 billion in value.

    For more information on Edgemont’s efforts in office-based physician specialties, including urgent care, occupational medicine, dermatology, and dental, contact Luke Mitchell at (212) 867-5181.

    Investment banking services are provided by Edgemont Capital Partners, LP, a registered broker-dealer and member of FINRA and SIPC.

    WorkWell Medical Group

    “After interviewing several firms we chose to work with Edgemont based on their long track record of working on behalf of medical practices and healthcare entrepreneurs, and their commitment to helping us achieve our personal and professional goals. From the beginning of the engagement, Luke and the Edgemont team demonstrated a strong understanding of our business, and were able to effectively communicate our vision and strategy to the universe of potential partners.  The Edgemont team provided exceptional advice and brought us a range of highly attractive, and actionable, strategic options that resulted in a great outcome for us, WorkWell, our employees, and our customers.”

    Dr. Sheilaja Mittal and Vikram Mittal
    WorkWell Medical Group

  • Array
    (
        [0] => http://i0.wp.com/www.edgemontcapital.com/wp-content/uploads/2015/09/52-Top-9-28-15.jpg?fit=248%2C70
        [1] => 248
        [2] => 70
    )
    
  • TRANSACTION OVERVIEW
    acquired by
    September 2015
    • New Jersey Anesthesia Associates
    • Limited Exclusive Sale
    • Livingston, NJ
    • Dr. Rae Pak, CEO
    • Edgemont Capital Partners acted as exclusive financial advisor to NJAA in its sale to MEDNAX
    • Confidential
    • NJAA is the anesthesiology services provider to Saint Barnabas Medical Center and Newark Beth Israel Medical Center as well as numerous surgery centers and office locations

    Case Study: New Jersey Anesthesia Associates

    Edgemont served as the exclusive financial advisor to New Jersey Anesthesia Associates (“NJAA”) in its sale to MEDNAX

    • Edgemont was retained by NJAA in early 2015 to advise the partnership on its strategic options after NJAA received an initial offer from a private equity-backed strategic acquirer
      • Initial offer contained a significant equity and earn-out component
      • Proposal was for the physician practice and excluded the management company
    • Edgemont’s preliminary valuation work confirmed NJAA’s belief that the initial offer significantly undervalued NJAA
      • Significant concerns about the feasibility of the earn-out and value of the equity component of the offer
      • Management and billing company also served other clients and would be left in limbo
    • Edgemont performed a full analysis of NJAA’s strategic and financial options
      • Our analysis concluded an auction process among multiple strategic acquirers was the best alternative
      • The process involved the sale of both the practice and the management company in one transaction
    • Edgemont received initial bids in mid-2015
      • Four attractive and competitive initial offers from other strategic acquirers
    • Edgemont worked with NJAA to interview and retain a transaction legal firm
    • Edgemont took second round bidders through a full diligence process and requested final bids in the form of a marked-up purchase contract
      • Competitive final bidding concluded with a sale to MEDNAX on very attractive terms
      • Final purchase price was significantly higher than the offer received prior to Edgemont’s engagement
      • Final purchase price was significantly higher than the initial round offers

    Edgemont Capital Partners Completes Sale of New Jersey Anesthesia Associates to MEDNAX

    Healthcare investment banking firm serves as exclusive financial advisor to NJAA, one of the largest independent anesthesia physician groups in the Northeast

    NEW YORK and LIVINGSTON, N.J., September 28, 2015 — Edgemont Capital Partners, LP, a leading independent investment banking firm providing M&A advisory services to healthcare companies, today announced that it has acted as exclusive financial advisor to New Jersey Anesthesia Associates, PC and its affiliated management company, Health Network Management, LLC (collectively “NJAA”) in its sale to MEDNAX, Inc. (NYSE: MD). Terms of the transaction were not disclosed.

    NJAA, established in 1996, provides anesthesia department management and staffing for Saint Barnabas Medical Center and Newark Beth Israel Medical Center, two of the largest health care providers in New Jersey, as well four ambulatory surgery centers and five outpatient facilities, and chronic pain services at five pain centers.  The transaction closed on September 25, 2015.  Jeff Swearingen, managing director, co-founder of Edgemont, and head of the firm’s Physician Services Group, led the Edgemont engagement team, along with Luke Mitchell, Vitaliy Marchenko and Anish Dalsania.  Brent Hill and Amanda Jester of Waller Lansden Dortch & Davis, LLP acted as legal counsel to NJAA in the transaction.

    “Physician practice consolidation has accelerated in 2015 as the rollout of the Patient Protection and Affordable Care Act continues to create upheaval, increased complexity, and financial pressure in the provision of healthcare services.  This environment has led many anesthesia and other hospital-based specialty practices to sell or merge their practices into larger organizations that offer greater management depth, better access to capital, economies of scale, IT and other expertise to support physician practices.  We believe this trend will continue and the pace of consolidation will accelerate,” said Mr. Swearingen.

    The sale of NJAA is Edgemont’s sixth closed transaction on behalf of hospital-based physician groups and management companies and fourth in anesthesia.  Edgemont has now served as exclusive advisor to anesthesia practices and management companies that account for approximately 400,000 annual cases.  Edgemont previously represented Milford Anesthesia Associates in its sale to Envision Healthcare Holdings, Inc. (NYSE: EVHC); South Oakland Anesthesia Associates in its sale to MEDNAX, Inc. (NYSE: MD); and Wolverine Anesthesia Consultants in its sale to TeamHealth Holdings Inc. (NYSE: TMH).  Edgemont also advised Premier Physician Services, Inc. in its sale to TeamHealth Holdings Inc. (NYSE: TMH), and Practice Support Resources, LLC in its sale to Intermedix Corporation.

    “Independent, high quality physician practices of scale are seeking the highest level of quality and experience in the financial advisors they hire.  Edgemont is unsurpassed in its success in advising physician practices,” added Mr. Swearingen.

    NJAA employs 90 full-time clinicians (70 anesthesiologists, 13 anesthetists, two nurse practitioners and five physician assistants) that provide a full spectrum of anesthesia services at Saint Barnabas Medical Center (SBMC), a 577-bed non-profit teaching hospital, and Newark Beth Israel Medical Center. SBMC is the oldest and largest non-profit, nonsectarian hospital in New Jersey, serving more than 32,500 inpatients annually and together with Barnabas Health Ambulatory Center, more than 300,000 outpatients annually.

    Both hospitals are part of Barnabas Health, New Jersey’s largest integrated health care delivery system. In addition, the practice provides anesthesia services at four ambulatory surgery centers and five outpatient facilities, and chronic pain services at five pain centers.

    NJAA provides services in collaboration with highly advanced acute-care programs at Barnabas Health. The practice’s anesthesia services include general anesthesia, cardiac, obstetric, transplant, critical care, chronic pain and acute pain management for post-operative pain. More than 20 of NJAA’s physicians hold advanced training in anesthesia sub-specialties, particularly cardiac and pediatric anesthesia, or multiple board certifications. NJAA also supports the health system’s advanced care programs through cardiac anesthesia fellowships, residency programs, management of post-operative care of cardiac surgery patients, and participation in a perioperative surgical home collaborative.

    “Edgemont’s anesthesia industry knowledge and transaction expertise allowed NJAA to realize an exceptional result that exceeded our expectations,” said Dr. Rae Pak, Chief Executive Officer of NJAA.  “Jeff and the Edgemont team possess a deep understanding of anesthesia services and their commitment to achieving the best outcome allowed our shareholders to maximize value and to partner with an industry leader that provides long term stability for our providers and staff.

    “We selected Edgemont over other firms we interviewed based on their proven track record in anesthesia services, renowned client service and the clear expertise they demonstrated during our investment banker evaluation process. The success of this transaction confirms that we made the best possible choice in electing to retain Edgemont as our M&A advisor,” Dr. Pak said.

    About Edgemont Capital Partners, L.P.

    Edgemont Capital Partners, LP (www.edgemontcapital.com) is a leading independent investment banking firm founded in 2001 providing the highest quality strategic advisory and capital raising services to healthcare companies.  The firm’s deep healthcare industry knowledge, broad relationship network and extensive transaction expertise allows Edgemont to address healthcare companies’ strategic and financing needs with great success. The firm’s principals have closed over 100 transactions, representing more than $30 billion in value.

    For more information on Edgemont’s efforts in Physician Services contact Jeff Swearingen at +1 (212) 867-8938.

    Investment banking services are provided by Edgemont Capital Partners, LP, a registered broker-dealer and member of FINRA and SIPC.

    New Jersey Anesthesia Associates

    "We selected Edgemont over other firms we interviewed based on their proven track record in anesthesia services, renowned client service and the clear expertise they demonstrated during our investment banker evaluation process. The success of this transaction confirms that we made the best possible choice in electing to retain Edgemont as our M&A advisor."

    Dr. Rae Pak
    CEO

    NJAA

  • Array
    (
        [0] => http://i2.wp.com/www.edgemontcapital.com/wp-content/uploads/2015/09/51-Top-2.png?fit=207%2C62
        [1] => 207
        [2] => 62
    )
    
  • TRANSACTION OVERVIEW
    Service Business acquired by
    July 2015
    • SCYNEXIS
    • Broad Exclusive Sale
    • Durham, NC
    • Marco Taglietti, M.D., CEO / Public
    • Edgemont Capital Partners acted as exclusive financial advisor to SCYNEXIS in the sale of their Service Business to Avista Pharma Solutions, an Ampersand Portfolio Company
    • Confidential
    • Contract Development and Manufacturing Organization (CDMO) for Animal and Human Health pharmaceuticals

    Pharmaceutical Services Case Studies

    Case Study: SCYNEXIS

    • SCYNEXIS Retained Edgemont in Sept 2014 to perform a review of strategic alternatives
    • Edgemont presented its recommendations to the board in Oct 2014
    • The board elected to pursue Edgemont’s recommendation to divest its contract research and development services business in order to focus on its drug development activities, including its lead, compound SCY-078
    • Edgemont conducted a broad marketing process to secure a buyer for the services business, which resulted in the sale of the business to Avista Pharma Solutions. Avista is a business unit of Accuratus Lab Services, Inc. Accuratus is a portfolio company of Ampersand Capital Partners.

    Edgemont Capital Partners Completes Sale of SCYNEXIS Contract Research and Development Business to Avista Pharma Solutions, an Ampersand Capital Partners Portfolio Company

    NEW YORK & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Today Edgemont Capital Partners, a leading independent investment banking firm providing merger and acquisition advisory services to healthcare companies, announced that it acted as exclusive financial advisor to SCYNEXIS, Inc. in the sale of its contract research and development services business to Avista Pharma Solutions. The deal was announced on July 23.

    SCYNEXIS, a pharmaceutical company committed to the discovery, development and commercialization of novel anti-infectives to address significant unmet therapeutic needs, divested its contract research and development business to focus on development of its lead compound SCY-078. The contract research and development business includes a novel screening platform and technology utilized by leading animal health companies, as well as Good Manufacturing Practices Active Pharmaceutical Ingredient (GMP API) process chemistry and analytical service offerings for biotech and pharmaceutical companies. The transaction was led by David Blume, Managing Director and Head of the firm’s Pharmaceutical Services Group, Reid Petersen and Anish Dalsania.

    “We are pleased to be part of this ‘win-win’ transaction which will allow SCYNEXIS to focus on development of its lead asset SCY-078 and provide a strong platform for this exceptional contract research, development and manufacturing business to capitalize on the strong market demand given the robust market conditions for outsourced pharmaceutical services,” said Blume.

    “Edgemont was instrumental to us achieving our goals in this transaction, providing valuable advice and flawless execution. We are grateful for their efforts,” commented Dr. Marco Taglietti, CEO of SCYNEXIS.

    As part of the transaction, Avista will occupy SCYNEXIS’ former research and GMP manufacturing facility in Durham, North Carolina and hire substantially all employees associated with the contract services research and development business. Avista is a contract development and manufacturing organization (CDMO) formed through the recent, strategic carve-outs of the CMC business of Array BioPharma, Inc. and contract services business of SCYNEXIS. Avista’s CEO is Patrick Walsh. Avista is a business unit of Accuratus Lab Services, Inc. (Accuratus). Accuratus is a portfolio company of Ampersand Capital Partners.

    About Edgemont Capital Partners

    Edgemont Capital Partners, LP (www.edgemontcapital.com) is an independent investment banking firm founded in 2001 providing merger and acquisition and financing advisory services to healthcare companies. The firm’s deep healthcare industry knowledge and extensive transaction expertise allows it to address healthcare companies’ strategic (M&A) and financing needs with great success. The firm’s principals have closed over 100 transactions, representing more than $30 billion in value.

    For more information on Edgemont Capital Partners’ expertise in pharmaceutical services and other healthcare sectors contact David Blume at +1 (212) 867-8937 and visit www.edgemontcapital.com.

    Investment banking services are provided by Edgemont Capital Partners, LP, a registered broker-dealer and member firm of FINRA and SIPC.

    SCYNEXIS

    “Edgemont was instrumental to us achieving our goals in this transaction, providing valuable advice and flawless execution. We are grateful for their efforts.”

    Dr. Marco Taglietti
    CEO

    SCYNEXIS

  • Array
    (
        [0] => http://i2.wp.com/www.edgemontcapital.com/wp-content/uploads/2015/09/1-Top-NEW-revised-9-11-15.png?fit=250%2C133
        [1] => 250
        [2] => 133
    )
    
  • TRANSACTION OVERVIEW
    acquired by
    December 2014
    • Siren Interactive
    • Broad Exclusive Sale
    • Chicago, IL
    • Wendy White, Founder & CEO
    • Edgemont Capital Partners acted as exclusive financial advisor to Siren Interactive in its sale to Dohmen
    • Confidential
    • Siren is the leading interactive communications company focused entirely on rare disease patients and their caregivers

    Edgemont Capital Serves as Exclusive Financial Advisor to Siren Interactive in Recently Announced Sale of Company to Dohmen Life Sciences Services

    NEW YORK and CHICAGO, (March 24, 2015) – Edgemont Capital Partners, LP, a leading independent investment banking firm providing merger and acquisition advisory services to healthcare companies, acted as exclusive financial advisor to Siren Interactive (“Siren”) in the recently announced sale of the company to Dohmen Life Science Services (“DLSS”), a subsidiary of the Dohmen Company, Edgemont said today. The transaction was originally announced on January 6.

    Siren is a leading rare disease interactive relationship marketing company with expertise in addressing the challenges and unmet needs of patients, caregivers, and physicians dealing with the over 7,000 rare diseases affecting over 300 million people worldwide. Edgemont Capital Partners acted as the exclusive financial advisor to Siren in the transaction, which closed on December 31, 2014. David Blume, Managing Director and head of the firm’s Pharmaceutical Services Group, and Luke Mitchell, Managing Director led Edgemont’s transaction team.

    “The needs of rare disease patients, their caregivers and physicians, are underserved. Despite greater awareness of the large number of rare diseases and those living with these conditions, access to information, including available therapies, care management, as well as patient and caregiver support through patient communities and effective ongoing communication remains a large unmet need. The development and introduction of pharmaceuticals to treat rare diseases is accelerating rapidly, increasing demand for services that optimally support access to and proper use of these therapies as part of the patient’s overall care,” said Blume.

    Siren Interactive serves rare disease pharmaceutical and biotech companies by connecting patients with their brands.  Siren is a pioneer in patient-driven decision making in commercialization of orphan drugs. Wendy White, president of Siren, founded the company as a result of her own personal struggle with a family member’s rare disease experience. Following the transaction, White joined DLSS as Senior Vice President of Dohmen’s Rare Disease segment.

    “We retained Edgemont to advise us based on their proven track record and expertise in pharmaceutical services and M&A execution. They demonstrated a commitment to our transaction and provided exceptional advice. As the founder and CEO of a premium services company I appreciate when a professional services organization goes the extra mile as Edgemont did for us,” White commented.

    About Dohmen Life Science Services

    Intelligent outsourcing for the life sciences.™

    Dohmen Life Science Services provides outsourced insight and infrastructure to entrepreneurs seeking speed, scale and certainty as they bring their biopharma or medical device products to market. Our industry experts help hundreds of companies preserve capital, mitigate risk and stay focused on the future by supplying the very best people, processes and tools within the areas of finance, technology, quality, regulatory compliance, supply chain, customer services and patient support. Dohmen Life Science Services is a subsidiary of the Dohmen Company. Privately held and headquartered in Milwaukee, Wisconsin, Dohmen has been finding ways to create a more efficient, effective and accessible healthcare supply system since 1858. More information can be found at DLSS.com and Dohmen.com.

    About Siren

    Siren Interactive is a rare disease marketing agency with unmatched expertise in addressing the challenges and unmet needs of patients, caregivers, and physicians dealing with the over 7,000 rare diseases affecting over 300 million people worldwide. For more than 15 years, across more than 30 different disease states, the Company has had a singular focus: Finding rare disease patients and connecting them to its clients’ brands. As trailblazers in recognizing that patient-driven decision making is central to successful orphan drug commercialization, Siren constantly innovates to meet patients and caregivers where they live. To learn more about Siren’s proprietary approaches to building trust relationships with rare disease stakeholders visit sireninteractive.com. Siren Interactive is a subsidiary of Dohmen Life Science Services. More information can be found at DLSS.com.

    About Edgemont Capital Partners

    Edgemont Capital Partners, LP (www.edgemontcapital.com), is an independent investment banking firm founded in 2001 providing merger and acquisition and financing advisory services to healthcare companies worldwide. The firm’s deep healthcare industry knowledge and extensive transaction expertise allows Edgemont to address healthcare companies’ strategic (M&A) and financing needs with great success. The firm’s principals have closed over 100 transactions, representing more than $30 billion in value.

    For more information on Edgemont Capital Partners’ expertise in pharmaceutical services or other healthcare sectors contact David Blume at +1 (212) 867-8937 and visit www.edgemontcapital.com.

    Investment banking services are provided by Edgemont Capital Partners, L.P., a registered broker-dealer and member of FINRA and SIPC.

    Siren Interactive

    “We retained Edgemont to advise us based on their proven track record and expertise in pharmaceutical services and M&A execution. They demonstrated a commitment to our transaction and provided exceptional advice. As the founder and CEO of a premium services company I appreciate when a professional services organization goes the extra mile as Edgemont did for us.”

    Wendy White
    President and Founder
    Siren Interactive 

  • Array
    (
        [0] => http://i2.wp.com/www.edgemontcapital.com/wp-content/uploads/2016/01/2-Top1_2e431c3b2b3b520b8396ae71b41b7e37.jpg?fit=249%2C67
        [1] => 249
        [2] => 67
    )
    
  • TRANSACTION OVERVIEW
    acquired by
    October 2014
    • Premier Physician Services
    • Limited Exclusive Sale
    • Dayton, OH
    • Bill Cole, M.D., CEO / Partnership
    • Edgemont Capital Partners acted as exclusive financial advisor to Premier Physician Services in its sale to TeamHealth
    • Confidential
    • Premier is a leading outsourced emergency department (ED) staffing and services provider operating in 74 locations in seven states in the Midwest

    Edgemont’s Hospital Outsourced Clinical Services Case Studies

    Case Study: Premier Physicians Services

    Edgemont served as the exclusive financial advisor to Premier Physician Services (“Premier”) in its sale to TeamHealth

    • Premier had grown to over 700 clinicians with over 300 shareholders and while continuing to experience growth and profitability, was facing some near-term challenges
    • Premier’s size and strong reputation made it the subject of regular acquisition inquiries
    • Edgemont was retained by Premier in 2013 to advise the Board on a range of strategic and financial transaction options
      • Divestiture of billing division
      • Leveraged share repurchase
      • Merger
      • Sale of Premier
    • Edgemont prepared a valuation for Premier’s Board looking at potential valuations and transaction structures under a range of transaction alternatives
      • Edgemont utilized our understanding of the potential synergies available to an acquirer in a sale transaction based on our HOCS industry experience
    • Edgemont contacted parties to generate initial proposals for a merger, a sale, and a divestiture of the billing division
    • Premier’s senior leadership met with potential partners and reviewed proposals in detail with Edgemont from a strategic, valuation, structure, and tax perspective
    • Premier elected to pursue a sale to TeamHealth
      • Transaction closed in October 2014
      • Compelling valuation for shareholders with very strong support from Premier’s hospital clients

     

    Edgemont Capital Partners Completes Sale Of Premier Physician Services To TeamHealth

    Healthcare investment banking firm serves as exclusive financial advisor to Premier, one of the largest independent Emergency Medicine physician groups in the U.S.

    NEW YORK and DAYTON, October 22, 2014 — Edgemont Capital Partners, L.P., a leading independent investment banking firm providing M&A advisory services to healthcare companies, today announced that it has acted as exclusive financial advisor to Premier Physician Services, Inc. (“Premier”) in the sale of the company to TeamHealth Holdings Inc. (NYSE:TMH). Terms of the transaction were not disclosed.

    Premier was established in 1987 and provides emergency department, hospital medicine, correctional care and occupational medicine management and staffing for facilities in Ohio and six other states. The transaction closed on October 21, 2014, and was led by Jeff Swearingen,
    managing director and co-founder of Edgemont Capital Partners, L.P., and head of Edgemont’s Physician Services Group.

    Physician practice consolidation has accelerated in 2014 as the rollout of the Patient Protection and Affordable Care Act drives significant change and increased complexity in healthcare. This operating environment has led many Emergency Medicine and other hospitalbased specialty practices to sell or merge their practices into large organizations that offer greater management depth, access to capital, and IT expertise to support physician practices. We believe this trend will only continue to accelerate, said Mr. Swearingen.

    Edgemont’s role as Premier’s exclusive advisor marks the firm’s fifth successfully closed transaction on behalf of hospital-based physician groups and management companies. Edgemont previously represented Milford Anesthesia Associates in its sale to Envision Healthcare Holdings, Inc. (formerly known as EmCare) (NYSE: EVHC), South Oakland Anesthesia Associates in its sale to MEDNAX, Inc. (NYSE: MD), Practice Support Resources, LLC in its sale to Intermedix Corporation, and Wolverine Anesthesia Consultants in its sale to TeamHealth Holdings Inc. (NYSE: TMH).

    Independent, high quality physician practices of scale are seeking the highest level of quality and experience in the financial advisors they hire. Edgemont has had an unparalleled level of success advising physician practices, added Mr. Swearingen.

    Based in Dayton, Ohio, Premier’s more than 700 physicians and advanced practice clinicians provide emergency department, hospital medicine, correctional care and occupational medicine management and staffing for 42 emergency departments, seven hospital medicine programs, 11 occupational medicine programs and 14 correctional care programs. Premier provides care for more than one million patients annually.

    Right from the start, Jeff and the Edgemont team demonstrated a strong understanding of the Emergency Medicine business and a real commitment to providing great service and the right advice, said Dr. Bill Cole, Chief Executive Officer of Premier.

    Edgemont’s market insight and strong execution resulted in a great transaction for Premier’s shareholders, with a partner that will provide the tools and resources to better serve our hospital clients.

    About Edgemont Capital Partners, L.P.

    Edgemont Capital Partners, L.P. (www.edgemontcapital.com) is a specialty M&A advisory firm dedicated to providing the highest quality strategic advisory and capital raising services to healthcare companies. The firm’s deep healthcare industry knowledge, extensive relationship network and substantial transaction expertise allows Edgemont to address healthcare companies’ strategic and financing needs with great success. Edgemont Capital Partners, L.P. provides sell-side and acquisition advisory, restructuring advisory, board advisory and private placement services.

    For more information on Edgemont Capital Partners, L.P.’s efforts in Physician Services contact Jeff Swearingen at +1 (212) 867-8938.

    Investment banking services are provided by Edgemont Capital Partners, L.P., a registered broker-dealer and member of FINRA and SIPC.

    Premier Physician Services

    “Right from the start, Jeff and the Edgemont team demonstrated a strong understanding of the Emergency Medicine business and a real commitment to providing great service and the right advice. Edgemont’s market insight and strong execution resulted in a great transaction for Premier’s shareholders, with a partner that will provide the tools and resources to better serve our hospital clients.”

    Dr. Bill Cole
    CEO
    Premier Physician Services

  • Array
    (
        [0] => http://i2.wp.com/www.edgemontcapital.com/wp-content/uploads/2015/09/6-Top1.png?fit=227%2C120
        [1] => 227
        [2] => 120
    )
    
  • TRANSACTION OVERVIEW
    recapitalized by
    April 2014
    • St. Louis Clinical Trials
    • Limited Exclusive Sale / Recapitalization
    • St. Louis, MO
    • Rick Mofsen, D.O., Founder & CEO
    • Edgemont Capital Partners acted as exclusive financial advisor to St. Louis Clinical Trials in its recapitalization and merger to form Evolution Research Group sponsored by DFW Capital
    • Confidential
    • SLCT is a leading clinical pharmacology and research services company focusing on psychiatric indications

Contact Us